Applied Genetic Technologies Corporation (NASDAQ: AGTC) In 2021: Is This Company Worth Thinking About Investing In?

This post was originally published on this site

In the last trading session, 0.82 million shares of the Applied Genetic Technologies Corporation (NASDAQ:AGTC) were traded, and its beta was 2.19. Most recently the company’s share price was $4.38, and it changed around $0.21 or 5.04% from the last close, which brings the market valuation of the company to $177.85M. AGTC currently trades at a discount to its 52-week high of $9.67, offering almost -120.78% off that amount. The share price’s 52-week low was $3.53, which indicates that the current value has risen by an impressive 19.41% since then. We note from Applied Genetic Technologies Corporation’s average daily trading volume that its 10-day average is 0.95 million shares, with the 3-month average coming to 1.31 million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Applied Genetic Technologies Corporation stock received a consensus recommendation rating of a Buy, based on a mean score of 1.70. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended AGTC as a Hold, whereas 8 deemed it a Buy, and 0 rated it as Underweight. Applied Genetic Technologies Corporation is expected to report earnings per share of -$0.39 for the current quarter.

Instantly AGTC has showed a green trend with a performance of 5.04% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 4.58 on Tuesday, 06/08/21 increased the stock’s daily price by 4.37%. The company’s shares are currently up 1.96% year-to-date, but still down -0.95% over the last five days. On the other hand, Applied Genetic Technologies Corporation (NASDAQ:AGTC) is 7.20% down in the 30-day period. We can see from the shorts that 5.18 million shares have been sold at a short interest cover period of 4.09 day(s).

The consensus price target as assigned by Wall Street analysts is $16.38, which translates to bulls needing to increase their stock price by 73.26% from its current value. Analyst projections state that AGTC is forecast to be at a low of $8.00 and a high of $35.00. In order for the stock price to hit the forecast high, the stock would need to plunge -699.09% from its current level, while the stock would need to crash -82.65% from its current level to reach the projected low.

Applied Genetic Technologies Corporation (AGTC) estimates and forecasts

Applied Genetic Technologies Corporation share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -11.09 percent over the past six months and at a 13.36% annual growth rate that is well above the industry average of 9.00%. Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will gain 30.40% in revenue this quarter, and will report an increase of 35.00% in the next quarter.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -7.80%.

AGTC Dividends

Applied Genetic Technologies Corporation’s next quarterly earnings report is expected to be released in July.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



Applied Genetic Technologies Corporation (NASDAQ:AGTC)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 0.66% of Applied Genetic Technologies Corporation shares, and 57.60% of them are in the hands of institutional investors. The stock currently has a share float of 57.99%. Applied Genetic Technologies Corporation stock is held by 111 institutions, with Blackrock Inc. being the largest institutional investor. By Mar 30, 2021, it held 6.99% of the shares, which is about 2.99 million shares worth $15.16 million.

Vanguard Group, Inc. (The), with 4.38% or 1.87 million shares worth $9.49 million as of Mar 30, 2021, holds the second largest percentage of outstanding shares.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Mar 30, 2021. The former held 1.08 million shares worth $5.49 million, making up 2.53% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 1.01 million shares worth around $5.1 million, which represents about 2.35% of the total shares outstanding.